Related Experiment Video
Updated: Jun 5, 2025

Quantitative Immunofluorescence to Measure Global Localized Translation
Published on: August 22, 2017
Examining the impact of the QUARTET USA trial using the translational science benefits model
Guhan Iyer1, Danielle Lazar2, Abigail S Baldridge3,4
1Cardiovascular Division and Global Health Center, Washington University in St. Louis., St. Louis. MO, USA.
Abstract:
Evaluation of benefits beyond quantitative academic outputs is essential in determining translational research value. We used the Translational Science Benefits Model (TSBM) to examine the impact of the QUARTET USA trial using 30 benefits across 4 domains: Clinical, Community, Economic, and Policy. We found that the QUARTET USA trial demonstrated impact in six areas within the Clinical, and Community domains and had potential impact in two additional areas within the Community and Economic domains. Use of the TSBM supports the value of the QUARTET USA trial, which can be used as a template for future cardiovascular trials.
More Related Videos
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
09:35A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
Published on: August 16, 2017